Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Low Molecular Weight Heparin Sodium Market Growth 2022-2028

  • LP 4743309
  • 93 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Low Molecular Weight Heparin Sodium will have significant change from previous year. According to our (LP Information) latest study, the global Low Molecular Weight Heparin Sodium market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Low Molecular Weight Heparin Sodium market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Low Molecular Weight Heparin Sodium market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Low Molecular Weight Heparin Sodium market, reaching US$ million by the year 2028. As for the Europe Low Molecular Weight Heparin Sodium landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Low Molecular Weight Heparin Sodium players cover Aspen, Sanofi-aventis, Pfizer, and Opocrin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Low Molecular Weight Heparin Sodium market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Enoxaparin

Dalteparin

Tinzaparin

Fraxiparine

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Medical

Research

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Aspen

Sanofi-aventis

Pfizer

Opocrin

CSBIO

Dongying Tiandong Pharmaceutica

Changzhou Qianhong Bio-pharma

Techdow

Yantai Dongcheng Pharmaceutical Group

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Low Molecular Weight Heparin Sodium Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Low Molecular Weight Heparin Sodium by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Low Molecular Weight Heparin Sodium by Country/Region, 2017, 2022 & 2028

2.2 Low Molecular Weight Heparin Sodium Segment by Type

2.2.1 Enoxaparin

2.2.2 Dalteparin

2.2.3 Tinzaparin

2.2.4 Fraxiparine

2.3 Low Molecular Weight Heparin Sodium Sales by Type

2.3.1 Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2022)

2.3.2 Global Low Molecular Weight Heparin Sodium Revenue and Market Share by Type (2017-2022)

2.3.3 Global Low Molecular Weight Heparin Sodium Sale Price by Type (2017-2022)

2.4 Low Molecular Weight Heparin Sodium Segment by Application

2.4.1 Medical

2.4.2 Research

2.5 Low Molecular Weight Heparin Sodium Sales by Application

2.5.1 Global Low Molecular Weight Heparin Sodium Sale Market Share by Application (2017-2022)

2.5.2 Global Low Molecular Weight Heparin Sodium Revenue and Market Share by Application (2017-2022)

2.5.3 Global Low Molecular Weight Heparin Sodium Sale Price by Application (2017-2022)

3 Global Low Molecular Weight Heparin Sodium by Company

3.1 Global Low Molecular Weight Heparin Sodium Breakdown Data by Company

3.1.1 Global Low Molecular Weight Heparin Sodium Annual Sales by Company (2020-2022)

3.1.2 Global Low Molecular Weight Heparin Sodium Sales Market Share by Company (2020-2022)

3.2 Global Low Molecular Weight Heparin Sodium Annual Revenue by Company (2020-2022)

3.2.1 Global Low Molecular Weight Heparin Sodium Revenue by Company (2020-2022)

3.2.2 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Company (2020-2022)

3.3 Global Low Molecular Weight Heparin Sodium Sale Price by Company

3.4 Key Manufacturers Low Molecular Weight Heparin Sodium Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Low Molecular Weight Heparin Sodium Product Location Distribution

3.4.2 Players Low Molecular Weight Heparin Sodium Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Low Molecular Weight Heparin Sodium by Geographic Region

4.1 World Historic Low Molecular Weight Heparin Sodium Market Size by Geographic Region (2017-2022)

4.1.1 Global Low Molecular Weight Heparin Sodium Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Low Molecular Weight Heparin Sodium Annual Revenue by Geographic Region

4.2 World Historic Low Molecular Weight Heparin Sodium Market Size by Country/Region (2017-2022)

4.2.1 Global Low Molecular Weight Heparin Sodium Annual Sales by Country/Region (2017-2022)

4.2.2 Global Low Molecular Weight Heparin Sodium Annual Revenue by Country/Region

4.3 Americas Low Molecular Weight Heparin Sodium Sales Growth

4.4 APAC Low Molecular Weight Heparin Sodium Sales Growth

4.5 Europe Low Molecular Weight Heparin Sodium Sales Growth

4.6 Middle East & Africa Low Molecular Weight Heparin Sodium Sales Growth

5 Americas

5.1 Americas Low Molecular Weight Heparin Sodium Sales by Country

5.1.1 Americas Low Molecular Weight Heparin Sodium Sales by Country (2017-2022)

5.1.2 Americas Low Molecular Weight Heparin Sodium Revenue by Country (2017-2022)

5.2 Americas Low Molecular Weight Heparin Sodium Sales by Type

5.3 Americas Low Molecular Weight Heparin Sodium Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Low Molecular Weight Heparin Sodium Sales by Region

6.1.1 APAC Low Molecular Weight Heparin Sodium Sales by Region (2017-2022)

6.1.2 APAC Low Molecular Weight Heparin Sodium Revenue by Region (2017-2022)

6.2 APAC Low Molecular Weight Heparin Sodium Sales by Type

6.3 APAC Low Molecular Weight Heparin Sodium Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Low Molecular Weight Heparin Sodium by Country

7.1.1 Europe Low Molecular Weight Heparin Sodium Sales by Country (2017-2022)

7.1.2 Europe Low Molecular Weight Heparin Sodium Revenue by Country (2017-2022)

7.2 Europe Low Molecular Weight Heparin Sodium Sales by Type

7.3 Europe Low Molecular Weight Heparin Sodium Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Low Molecular Weight Heparin Sodium by Country

8.1.1 Middle East & Africa Low Molecular Weight Heparin Sodium Sales by Country (2017-2022)

8.1.2 Middle East & Africa Low Molecular Weight Heparin Sodium Revenue by Country (2017-2022)

8.2 Middle East & Africa Low Molecular Weight Heparin Sodium Sales by Type

8.3 Middle East & Africa Low Molecular Weight Heparin Sodium Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Low Molecular Weight Heparin Sodium

10.3 Manufacturing Process Analysis of Low Molecular Weight Heparin Sodium

10.4 Industry Chain Structure of Low Molecular Weight Heparin Sodium

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Low Molecular Weight Heparin Sodium Distributors

11.3 Low Molecular Weight Heparin Sodium Customer

12 World Forecast Review for Low Molecular Weight Heparin Sodium by Geographic Region

12.1 Global Low Molecular Weight Heparin Sodium Market Size Forecast by Region

12.1.1 Global Low Molecular Weight Heparin Sodium Forecast by Region (2023-2028)

12.1.2 Global Low Molecular Weight Heparin Sodium Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Low Molecular Weight Heparin Sodium Forecast by Type

12.7 Global Low Molecular Weight Heparin Sodium Forecast by Application

13 Key Players Analysis

13.1 Aspen

13.1.1 Aspen Company Information

13.1.2 Aspen Low Molecular Weight Heparin Sodium Product Offered

13.1.3 Aspen Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Aspen Main Business Overview

13.1.5 Aspen Latest Developments

13.2 Sanofi-aventis

13.2.1 Sanofi-aventis Company Information

13.2.2 Sanofi-aventis Low Molecular Weight Heparin Sodium Product Offered

13.2.3 Sanofi-aventis Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi-aventis Main Business Overview

13.2.5 Sanofi-aventis Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Low Molecular Weight Heparin Sodium Product Offered

13.3.3 Pfizer Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Opocrin

13.4.1 Opocrin Company Information

13.4.2 Opocrin Low Molecular Weight Heparin Sodium Product Offered

13.4.3 Opocrin Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Opocrin Main Business Overview

13.4.5 Opocrin Latest Developments

13.5 CSBIO

13.5.1 CSBIO Company Information

13.5.2 CSBIO Low Molecular Weight Heparin Sodium Product Offered

13.5.3 CSBIO Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 CSBIO Main Business Overview

13.5.5 CSBIO Latest Developments

13.6 Dongying Tiandong Pharmaceutica

13.6.1 Dongying Tiandong Pharmaceutica Company Information

13.6.2 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Product Offered

13.6.3 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dongying Tiandong Pharmaceutica Main Business Overview

13.6.5 Dongying Tiandong Pharmaceutica Latest Developments

13.7 Changzhou Qianhong Bio-pharma

13.7.1 Changzhou Qianhong Bio-pharma Company Information

13.7.2 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Product Offered

13.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Changzhou Qianhong Bio-pharma Main Business Overview

13.7.5 Changzhou Qianhong Bio-pharma Latest Developments

13.8 Techdow

13.8.1 Techdow Company Information

13.8.2 Techdow Low Molecular Weight Heparin Sodium Product Offered

13.8.3 Techdow Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Techdow Main Business Overview

13.8.5 Techdow Latest Developments

13.9 Yantai Dongcheng Pharmaceutical Group

13.9.1 Yantai Dongcheng Pharmaceutical Group Company Information

13.9.2 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Product Offered

13.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Yantai Dongcheng Pharmaceutical Group Main Business Overview

13.9.5 Yantai Dongcheng Pharmaceutical Group Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Low Molecular Weight Heparin Sodium Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Low Molecular Weight Heparin Sodium Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Enoxaparin

Table 4. Major Players of Dalteparin

Table 5. Major Players of Tinzaparin

Table 6. Major Players of Fraxiparine

Table 7. Global Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)

Table 8. Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2022)

Table 9. Global Low Molecular Weight Heparin Sodium Revenue by Type (2017-2022) & ($ million)

Table 10. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2017-2022)

Table 11. Global Low Molecular Weight Heparin Sodium Sale Price by Type (2017-2022) & (USD/MT)

Table 12. Global Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)

Table 13. Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2022)

Table 14. Global Low Molecular Weight Heparin Sodium Revenue by Application (2017-2022)

Table 15. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2017-2022)

Table 16. Global Low Molecular Weight Heparin Sodium Sale Price by Application (2017-2022) & (USD/MT)

Table 17. Global Low Molecular Weight Heparin Sodium Sales by Company (2020-2022) & (K MT)

Table 18. Global Low Molecular Weight Heparin Sodium Sales Market Share by Company (2020-2022)

Table 19. Global Low Molecular Weight Heparin Sodium Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Company (2020-2022)

Table 21. Global Low Molecular Weight Heparin Sodium Sale Price by Company (2020-2022) & (USD/MT)

Table 22. Key Manufacturers Low Molecular Weight Heparin Sodium Producing Area Distribution and Sales Area

Table 23. Players Low Molecular Weight Heparin Sodium Products Offered

Table 24. Low Molecular Weight Heparin Sodium Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Low Molecular Weight Heparin Sodium Sales by Geographic Region (2017-2022) & (K MT)

Table 28. Global Low Molecular Weight Heparin Sodium Sales Market Share Geographic Region (2017-2022)

Table 29. Global Low Molecular Weight Heparin Sodium Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Low Molecular Weight Heparin Sodium Sales by Country/Region (2017-2022) & (K MT)

Table 32. Global Low Molecular Weight Heparin Sodium Sales Market Share by Country/Region (2017-2022)

Table 33. Global Low Molecular Weight Heparin Sodium Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Low Molecular Weight Heparin Sodium Sales by Country (2017-2022) & (K MT)

Table 36. Americas Low Molecular Weight Heparin Sodium Sales Market Share by Country (2017-2022)

Table 37. Americas Low Molecular Weight Heparin Sodium Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Low Molecular Weight Heparin Sodium Revenue Market Share by Country (2017-2022)

Table 39. Americas Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)

Table 40. Americas Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2022)

Table 41. Americas Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)

Table 42. Americas Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2022)

Table 43. APAC Low Molecular Weight Heparin Sodium Sales by Region (2017-2022) & (K MT)

Table 44. APAC Low Molecular Weight Heparin Sodium Sales Market Share by Region (2017-2022)

Table 45. APAC Low Molecular Weight Heparin Sodium Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Low Molecular Weight Heparin Sodium Revenue Market Share by Region (2017-2022)

Table 47. APAC Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)

Table 48. APAC Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2022)

Table 49. APAC Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)

Table 50. APAC Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2022)

Table 51. Europe Low Molecular Weight Heparin Sodium Sales by Country (2017-2022) & (K MT)

Table 52. Europe Low Molecular Weight Heparin Sodium Sales Market Share by Country (2017-2022)

Table 53. Europe Low Molecular Weight Heparin Sodium Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Low Molecular Weight Heparin Sodium Revenue Market Share by Country (2017-2022)

Table 55. Europe Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)

Table 56. Europe Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2022)

Table 57. Europe Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)

Table 58. Europe Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Low Molecular Weight Heparin Sodium Sales by Country (2017-2022) & (K MT)

Table 60. Middle East & Africa Low Molecular Weight Heparin Sodium Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Low Molecular Weight Heparin Sodium Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Low Molecular Weight Heparin Sodium Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)

Table 64. Middle East & Africa Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)

Table 66. Middle East & Africa Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Low Molecular Weight Heparin Sodium

Table 68. Key Market Challenges & Risks of Low Molecular Weight Heparin Sodium

Table 69. Key Industry Trends of Low Molecular Weight Heparin Sodium

Table 70. Low Molecular Weight Heparin Sodium Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Low Molecular Weight Heparin Sodium Distributors List

Table 73. Low Molecular Weight Heparin Sodium Customer List

Table 74. Global Low Molecular Weight Heparin Sodium Sales Forecast by Region (2023-2028) & (K MT)

Table 75. Global Low Molecular Weight Heparin Sodium Sales Market Forecast by Region

Table 76. Global Low Molecular Weight Heparin Sodium Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Low Molecular Weight Heparin Sodium Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Low Molecular Weight Heparin Sodium Sales Forecast by Country (2023-2028) & (K MT)

Table 79. Americas Low Molecular Weight Heparin Sodium Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Low Molecular Weight Heparin Sodium Sales Forecast by Region (2023-2028) & (K MT)

Table 81. APAC Low Molecular Weight Heparin Sodium Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Low Molecular Weight Heparin Sodium Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Europe Low Molecular Weight Heparin Sodium Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Low Molecular Weight Heparin Sodium Sales Forecast by Country (2023-2028) & (K MT)

Table 85. Middle East & Africa Low Molecular Weight Heparin Sodium Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Low Molecular Weight Heparin Sodium Sales Forecast by Type (2023-2028) & (K MT)

Table 87. Global Low Molecular Weight Heparin Sodium Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Low Molecular Weight Heparin Sodium Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Low Molecular Weight Heparin Sodium Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Low Molecular Weight Heparin Sodium Sales Forecast by Application (2023-2028) & (K MT)

Table 91. Global Low Molecular Weight Heparin Sodium Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Low Molecular Weight Heparin Sodium Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Low Molecular Weight Heparin Sodium Revenue Market Share Forecast by Application (2023-2028)

Table 94. Aspen Basic Information, Low Molecular Weight Heparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 95. Aspen Low Molecular Weight Heparin Sodium Product Offered

Table 96. Aspen Low Molecular Weight Heparin Sodium Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 97. Aspen Main Business

Table 98. Aspen Latest Developments

Table 99. Sanofi-aventis Basic Information, Low Molecular Weight Heparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 100. Sanofi-aventis Low Molecular Weight Heparin Sodium Product Offered

Table 101. Sanofi-aventis Low Molecular Weight Heparin Sodium Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 102. Sanofi-aventis Main Business

Table 103. Sanofi-aventis Latest Developments

Table 104. Pfizer Basic Information, Low Molecular Weight Heparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 105. Pfizer Low Molecular Weight Heparin Sodium Product Offered

Table 106. Pfizer Low Molecular Weight Heparin Sodium Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 107. Pfizer Main Business

Table 108. Pfizer Latest Developments

Table 109. Opocrin Basic Information, Low Molecular Weight Heparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 110. Opocrin Low Molecular Weight Heparin Sodium Product Offered

Table 111. Opocrin Low Molecular Weight Heparin Sodium Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 112. Opocrin Main Business

Table 113. Opocrin Latest Developments

Table 114. CSBIO Basic Information, Low Molecular Weight Heparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 115. CSBIO Low Molecular Weight Heparin Sodium Product Offered

Table 116. CSBIO Low Molecular Weight Heparin Sodium Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 117. CSBIO Main Business

Table 118. CSBIO Latest Developments

Table 119. Dongying Tiandong Pharmaceutica Basic Information, Low Molecular Weight Heparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 120. Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Product Offered

Table 121. Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 122. Dongying Tiandong Pharmaceutica Main Business

Table 123. Dongying Tiandong Pharmaceutica Latest Developments

Table 124. Changzhou Qianhong Bio-pharma Basic Information, Low Molecular Weight Heparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 125. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Product Offered

Table 126. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 127. Changzhou Qianhong Bio-pharma Main Business

Table 128. Changzhou Qianhong Bio-pharma Latest Developments

Table 129. Techdow Basic Information, Low Molecular Weight Heparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 130. Techdow Low Molecular Weight Heparin Sodium Product Offered

Table 131. Techdow Low Molecular Weight Heparin Sodium Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 132. Techdow Main Business

Table 133. Techdow Latest Developments

Table 134. Yantai Dongcheng Pharmaceutical Group Basic Information, Low Molecular Weight Heparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 135. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Product Offered

Table 136. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 137. Yantai Dongcheng Pharmaceutical Group Main Business

Table 138. Yantai Dongcheng Pharmaceutical Group Latest Developments

List of Figures

Figure 1. Picture of Low Molecular Weight Heparin Sodium

Figure 2. Low Molecular Weight Heparin Sodium Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Low Molecular Weight Heparin Sodium Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Low Molecular Weight Heparin Sodium Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Low Molecular Weight Heparin Sodium Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Enoxaparin

Figure 10. Product Picture of Dalteparin

Figure 11. Product Picture of Tinzaparin

Figure 12. Product Picture of Fraxiparine

Figure 13. Global Low Molecular Weight Heparin Sodium Sales Market Share by Type in 2021

Figure 14. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2017-2022)

Figure 15. Low Molecular Weight Heparin Sodium Consumed in Medical

Figure 16. Global Low Molecular Weight Heparin Sodium Market: Medical (2017-2022) & (K MT)

Figure 17. Low Molecular Weight Heparin Sodium Consumed in Research

Figure 18. Global Low Molecular Weight Heparin Sodium Market: Research (2017-2022) & (K MT)

Figure 19. Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2022)

Figure 20. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application in 2021

Figure 21. Low Molecular Weight Heparin Sodium Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Company in 2021

Figure 23. Global Low Molecular Weight Heparin Sodium Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Geographic Region in 2021

Figure 25. Global Low Molecular Weight Heparin Sodium Sales Market Share by Region (2017-2022)

Figure 26. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Country/Region in 2021

Figure 27. Americas Low Molecular Weight Heparin Sodium Sales 2017-2022 (K MT)

Figure 28. Americas Low Molecular Weight Heparin Sodium Revenue 2017-2022 ($ Millions)

Figure 29. APAC Low Molecular Weight Heparin Sodium Sales 2017-2022 (K MT)

Figure 30. APAC Low Molecular Weight Heparin Sodium Revenue 2017-2022 ($ Millions)

Figure 31. Europe Low Molecular Weight Heparin Sodium Sales 2017-2022 (K MT)

Figure 32. Europe Low Molecular Weight Heparin Sodium Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Low Molecular Weight Heparin Sodium Sales 2017-2022 (K MT)

Figure 34. Middle East & Africa Low Molecular Weight Heparin Sodium Revenue 2017-2022 ($ Millions)

Figure 35. Americas Low Molecular Weight Heparin Sodium Sales Market Share by Country in 2021

Figure 36. Americas Low Molecular Weight Heparin Sodium Revenue Market Share by Country in 2021

Figure 37. United States Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Low Molecular Weight Heparin Sodium Sales Market Share by Region in 2021

Figure 42. APAC Low Molecular Weight Heparin Sodium Revenue Market Share by Regions in 2021

Figure 43. China Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Low Molecular Weight Heparin Sodium Sales Market Share by Country in 2021

Figure 50. Europe Low Molecular Weight Heparin Sodium Revenue Market Share by Country in 2021

Figure 51. Germany Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Low Molecular Weight Heparin Sodium Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Low Molecular Weight Heparin Sodium Revenue Market Share by Country in 2021

Figure 58. Egypt Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Low Molecular Weight Heparin Sodium Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Low Molecular Weight Heparin Sodium in 2021

Figure 64. Manufacturing Process Analysis of Low Molecular Weight Heparin Sodium

Figure 65. Industry Chain Structure of Low Molecular Weight Heparin Sodium

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390